Histogen Price To Sales Ratio vs Average Payables Analysis
| HSTO Stock | USD 0.02 0.01 25.65% |
Histogen financial indicator trend analysis is much more than just examining Histogen latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Histogen is a good investment. Please check the relationship between Histogen Price To Sales Ratio and its Average Payables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.
Price To Sales Ratio vs Average Payables
Price To Sales Ratio vs Average Payables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Histogen Price To Sales Ratio account and Average Payables. At this time, the significance of the direction appears to have pay attention.
The correlation between Histogen's Price To Sales Ratio and Average Payables is -0.98. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Average Payables in the same time period over historical financial statements of Histogen, assuming nothing else is changed. The correlation between historical values of Histogen's Price To Sales Ratio and Average Payables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Histogen are associated (or correlated) with its Average Payables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Average Payables has no effect on the direction of Price To Sales Ratio i.e., Histogen's Price To Sales Ratio and Average Payables go up and down completely randomly.
Correlation Coefficient | -0.98 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Histogen stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Histogen sales, a figure that is much harder to manipulate than other Histogen multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most indicators from Histogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Histogen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.At this time, Histogen's Selling General Administrative is very stable compared to the past year. As of the 23rd of November 2024, Sales General And Administrative To Revenue is likely to grow to 4.44, though Issuance Of Capital Stock is likely to grow to (8.6 K).
| 2023 | 2024 (projected) | Total Revenue | 19K | 18.1K | Interest Income | 653.2K | 685.9K |
Histogen fundamental ratios Correlations
Click cells to compare fundamentals
Histogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Histogen fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 2.9M | 15.0M | 27.2M | 19.1M | 17.2M | 33.0M | |
| Other Current Liab | 440K | 2.1M | 764K | 424K | 381.6K | 362.5K | |
| Total Current Liabilities | 1.4M | 2.8M | 2.3M | 1.2M | 1.1M | 1.1M | |
| Total Stockholder Equity | (37.1M) | 7.9M | 21.2M | 14.4M | 13.0M | 16.4M | |
| Property Plant And Equipment Net | 415K | 4.7M | 4.8M | 5.1M | 5.9M | 6.2M | |
| Net Debt | (1.9M) | (1.5M) | (13.9M) | (7.5M) | (8.6M) | (9.0M) | |
| Retained Earnings | (43.9M) | (62.7M) | (77.7M) | (88.3M) | (79.4M) | (83.4M) | |
| Accounts Payable | 808K | 539K | 1.4M | 382K | 343.8K | 326.6K | |
| Cash | 2.1M | 6.8M | 18.7M | 12.1M | 10.9M | 12.3M | |
| Non Current Assets Total | 484K | 6.6M | 5.6M | 5.6M | 6.5M | 6.8M | |
| Non Currrent Assets Other | 69K | 1.9M | 805K | 523K | 601.5K | 1.1M | |
| Cash And Short Term Investments | 2.1M | 6.8M | 18.7M | 12.5M | 11.3M | 10.7M | |
| Common Stock Shares Outstanding | 590.7K | 450.9K | 1.9M | 3.2M | 2.9M | 4.5M | |
| Liabilities And Stockholders Equity | 2.9M | 15.0M | 27.2M | 19.1M | 17.2M | 33.0M | |
| Non Current Liabilities Total | 39.5M | 5.3M | 4.7M | 4.5M | 5.1M | 4.9M | |
| Other Current Assets | 167K | 1.2M | 2.4M | 848K | 975.2K | 1.4M | |
| Other Stockholder Equity | (32.2M) | 55.5M | 98.8M | 102.7M | 92.4M | 87.1M | |
| Total Liab | 40.9M | 8.1M | 7.1M | 5.7M | 5.1M | 4.9M | |
| Property Plant And Equipment Gross | 221K | 4.7M | 4.8M | 5.1M | 5.9M | 6.2M | |
| Total Current Assets | 2.5M | 8.4M | 21.6M | 13.5M | 12.1M | 11.5M | |
| Accumulated Other Comprehensive Income | (154.2K) | (34K) | (39.1M) | (15.0M) | (13.5M) | (12.8M) | |
| Other Assets | 69K | 6.3M | 805K | 523K | 601.5K | 571.4K | |
| Property Plant Equipment | 415K | 4.7M | 4.8M | 5.1M | 5.9M | 6.2M | |
| Current Deferred Revenue | 14.2M | 10.1M | 19K | 48K | 17.1K | 16.2K | |
| Net Receivables | 110K | 144K | 165K | 99K | 89.1K | 84.6K | |
| Other Liab | 138K | 118K | 112K | 79K | 71.1K | 67.5K | |
| Net Tangible Assets | (37.1M) | 7.9M | 21.2M | 14.4M | 16.6M | 17.4M | |
| Inventory | 106K | 300K | 1.7M | 400K | 460K | 716.7K |
Pair Trading with Histogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Histogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will appreciate offsetting losses from the drop in the long position's value.Moving against Histogen Stock
The ability to find closely correlated positions to Histogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Histogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Histogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Histogen to buy it.
The correlation of Histogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Histogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Histogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Histogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Histogen. If investors know Histogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Histogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.81) | Revenue Per Share 0.004 | Return On Assets (0.54) | Return On Equity (1.20) |
The market value of Histogen is measured differently than its book value, which is the value of Histogen that is recorded on the company's balance sheet. Investors also form their own opinion of Histogen's value that differs from its market value or its book value, called intrinsic value, which is Histogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Histogen's market value can be influenced by many factors that don't directly affect Histogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Histogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Histogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Histogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.